Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Yearly Tax Loss Harvesting Etfs describes a disciplined annual approach to harvest losses and refresh positions efficiently.
13,404 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Zenith Labs announced a new cross-chain bridge that lets the Canton network and Ethereum swap tokens via atomic swaps...
Global markets face renewed volatility as geopolitics and energy prices swing. CEOs are adopting a wartime mindset, r...
A federal jury in San Francisco ruled that Elon Musk misled Twitter investors ahead of the 2022 buyout, setting up a ...
History says you'll regret not buying Amazon stock if you wait for perfect timing. This guide breaks down the lessons...
Investors paused on news from Middle East diplomacy talks, pushing the Nasdaq Composite lower as rates and energy mar...
If you’re weighing Peloton as an investment, you’re not alone. This piece lays out two essential reasons I haven’t bo...
Bitcoin hovers around $70,000 after a brief pullback, as volatility eases and traders weigh whether this is the momen...
As AI reshapes business, three stock ideas stand out for potential multi-year gains. This guide breaks down why, how ...
Intel and AMD delivered contrasting Q4 results, highlighting divergent paths: Intel grappling with foundry losses ami...
Meta Platforms is pursuing a bold path toward a $9 trillion market cap by 2031. This article breaks down the feasibil...
Nike remains a heavyweight in athletic wear, but its stock has faced pressure. This guide breaks down whether should ...